A British baby’s death this year after getting Novartis’s gene therapy Zolgensma was not caused by a toxic drug reaction, the Swiss drugmaker said, allaying concerns over the $2.1 million-per-patient treatment’s risks.
An independent expert panel to the U.S. Food and Drug Administration on Wednesday recommended approval of GlaxoSmithKline Plc’s over-the-counter nicotine oral spray that aims to help smokers quit their addiction.
For two men trained as scientists, the bosses of Britain’s major insulin providers have had to become experts in ferry schedules, trucking laws and warehouse capacity as they seek to guarantee the supply of life-saving drugs through a chaotic Brexit.
With Britain sourcing the vast majority of the insulin needed by its 1 million diabetics from overseas, its biggest providers have had to restructure their supply chains in case a chaotic Brexit disrupts the normal arteries of trade.
Vintura is a strategy and organization consultancy firm in healthcare and life sciences with a diverse team of 25 experienced consultants. The firm was founded in 2000, and since then we have been supporting our clients with their strategic and organizational challenges and changes. Together with our clients, i.e. healthcare providers, pharmaceutical companies, manufacturers of medical devices and healthcare insurance companies, we increase the value of healthcare. Our mission is: ‘Creating meaningful impact in healthcare together’. Over time we’ve developed a wide and loyal customer base, both locally and internationally, with an average client satisfaction score of 8,5.